Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Jun 2012 07:00 AM
RNS
Placing
06 Jun 2012 07:00 AM
RNS
Placing
13 Mar 2012 02:33 PM
Issue of Options & Transfer of Shares
27 Feb 2012 07:01 AM
SAREUM HOLDINGS PLC : Research Update
27 Feb 2012 07:00 AM
SAREUM HOLDINGS PLC : Half-yearly report
30 Jan 2012 07:00 AM
RNS
Notice of Results
14 Dec 2011 11:51 AM
SAREUM HOLDINGS PLC : Result of AGM
14 Dec 2011 11:51 AM
SAREUM HOLDINGS PLC : Result of AGM
11 Nov 2011 07:00 AM
RNS
Sareum to present at International Conference
04 Nov 2011 02:29 PM
RNS
Report & Accounts & Notice of AGM Available
26 Sep 2011 07:00 AM
Final Results
14 Sep 2011 07:00 AM
RNS
Sareum to present at European Cancer conference
15 Aug 2011 07:00 AM
Preclinical Development Candidate Selected for ...
23 May 2011 10:32 AM
RNS
Website Update
12 May 2011 07:00 AM
RNS
Sareum to Present at Oncology Leadership Meeting
07 Mar 2011 05:20 PM
Director/PDMR Shareholding
04 Mar 2011 10:11 AM
Research Update: Positive Chk1 Programme Model ...
28 Feb 2011 10:36 AM
Total voting rights
21 Feb 2011 07:00 AM
Half-yearly report
10 Feb 2011 07:00 AM
Issue of Equity
09 Feb 2011 10:22 AM
Statement re Share Price Movement
07 Feb 2011 06:00 AM
Research Update: Positive Leukaemia Model Study
31 Dec 2010 06:00 AM
Total voting rights
22 Dec 2010 07:00 AM
Issue of Options
15 Dec 2010 11:44 AM
Result of AGM
13 Dec 2010 07:00 AM
SAR Placing
02 Dec 2010 04:02 PM
Holding(s) in Company
25 Oct 2010 07:00 AM
Sareum to present at major research congress in...
22 Oct 2010 07:00 AM
Final Results
09 Sep 2010 02:44 PM
Holding(s) in Company
02 Sep 2010 11:41 AM
Holding(s) in Company
31 Aug 2010 12:06 PM
Total voting rights
03 Aug 2010 07:00 AM
RNS
Issue of Equity
12 Jul 2010 07:00 AM
RNS
Adviser - change of name
05 May 2010 07:00 AM
RNS
Sareum to Present at BIO 2010
26 Apr 2010 07:00 AM
RNS
Scientific Advisory Board App
16 Mar 2010 07:00 AM
RNS
Collaboration Agreement
16 Feb 2010 07:00 AM
RNS
Half Yearly Report
20 Jan 2010 07:00 AM
RNS
The ICR, Sareum and CRT Limit
16 Dec 2009 11:01 AM
RNS
Result of AGM
04 Dec 2009 03:18 PM
RNS
Issue of options
24 Nov 2009 05:05 PM
RNS
Holding(s) in Company
20 Nov 2009 07:00 AM
RNS
Availability of Report & Acco
02 Nov 2009 07:00 AM
RNS
Sareum to Present at BIO-Euro
30 Oct 2009 07:00 AM
RNS
Total Voting Rights
27 Oct 2009 07:00 AM
RNS
Final Results
19 Oct 2009 02:49 PM
RNS
Holding(s) in Company
19 Oct 2009 07:00 AM
RNS
NOMAD - change of name
15 Oct 2009 09:52 AM
RNS
Holding(s) in Company
12 Oct 2009 05:02 PM
RNS
Issue of Equity

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

It listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings